ArticleClinical oral investigations2018

Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor.

Jitjiroj Ittichaicharoen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.